Ornella Moreggia
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine.
Journal: Frontiers in immunology
Published: December 22, 2025
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data.
Journal: Pharmacological reports : PR
Published: January 09, 2025
Epstein-Barr virus infection in patients with MOGAD.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 13, 2024
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis.
Journal: European journal of neurology
Published: October 11, 2024
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system.
Journal: Frontiers in neurology
Published: February 08, 2024
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis.
Journal: Journal of clinical medicine
Published: May 30, 2023
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study.
Journal: Journal of clinical medicine
Published: October 21, 2022
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies.
Journal: Multiple sclerosis and related disorders
Published: August 30, 2022
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects.
Journal: Multiple sclerosis and related disorders
Published: March 09, 2022
Flu vaccination in multiple sclerosis patients: a monocentric prospective vaccine-vigilance study.
Journal: Expert opinion on drug safety
Published: February 22, 2022
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects.
Journal: Multiple sclerosis and related disorders
Published: October 27, 2021
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report.
Journal: Frontiers in neurology
Published: June 07, 2021
Last Updated: 09/26/2026